Cancer Screen Week 2021According to the American Cancer Society, almost 608,570 people are expected to die from cancer in 2021. Regular screening can help find certain cancers early when they are most likely to be treated successfully. This Cancer Screen Week (Dec 6-10), helps us raise awareness and learn more of the potentially lifesaving benefits…
Trigeminal neuralgia (TN) is a rare and excruciating nerve disorder that can occur when a blood vessel compresses the trigeminal nerve, the largest nerve in the head, and causes debilitating pain in various parts of the face and jaw region. Trigeminal neuralgia is usually categorized as typical or atypical, with symptoms differing depending on the…
As the COVID-19 pandemic continues, many cancer patients are having to make the difficult decision to continue with their current cancer regimen or delay treatments. Cancer patients and physicians must carefully weigh the potential benefit of routine cancer care versus the risk of COVID-19. To help ease these decisions, several peer-reviewed, non-profit cancer care organizations…
Two clinical trials opened for enrollment in late 2019 at UofL Health – James Graham Brown Cancer Center for eligible men with prostate cancer. “Since the Brown Cancer Center has these clinical trials available, we can offer our prostate cancer patients the latest cancer treatments,” Scott Silva, M.D., Ph.D. , radiation oncologist, said. Men with favorable intermediate risk…
Vernon Traxler suffered from painful trigeminal neuralgia for over 16 years before he found relief with CyberKnife. Watch Vernon explain what those years felt like and how he feels now after being treated by CyberKnife.
When deciding which treatment option is best for their prostate cancer, men take numerous factors into consideration. While their physician’s recommendation does play an important role in the treatment decision, in the end, most men make the choice that is best for them. That choice is often based on treatment outcomes and side effects, and…
Check out this infographic from the Centers for Disease Control and Prevention (CDC) regarding African-American men and lung cancer.
Accuray Incorporated, developer and manufacturer of the CyberKnife® System, announced that published data from two multicenter studies using differing protocols provide consistent results and reinforce the use of the CyberKnife system for the effective management of low-and intermediate-risk prostate cancer. The studies are the largest conducted to date evaluating stereotactic body radiation therapy (SBRT) in…
When it comes to fighting cancer, it takes a team of people. Treatment at our center means that you are not alone in the fight. Cancer treatments are rapidly advancing and having a research focused team of radiation oncologists enables us to bring you the most up-to-date approaches to fighting your specific cancer. In cancer…
June is National Cancer Survivor Month, a time to celebrate and recognize cancer survivors, inspire those recently diagnosed, and, most importantly, to celebrate life. During the month, cancer survivors and supporters in communities around the world unite to celebrate life and raise awareness of the challenges faced by cancer survivors. It is a time for…
